Clinical trial · Observational
Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
NCT06830590CI-TRIAL-00093546BrCarecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Molecular Pathway Deregulation | — | UNRESOLVED | — |
| Treatment | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Molecular characterisation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Early operable primary breast cancer
- description
- 1. women 2. any age group 3. confirmed diagnosis of breast cancer
- interventionNames
- Procedure: Molecular characterisation
Primary outcomes (1)
- measure
- Breast cancer specific survival in correlation with molecular pattern
- timeFrame
- 10 years
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC Exclusion Criteria: * patients received pre-operative chemotherapy or radiotherapy
References
Publications (0)
Data not yet available
No reference posted for this study.